Dr Lal PathLabs, one of the largest lab testing companies in India, left a huge cache of patient data on a public server for months, TechCrunch has learned. The lab testing giant, headquartered in New ...

An Indian health official uses a swab to collect sample from a woman to conduct tests for the coronavirus disease (COVID-19), amid the spread of the disease, at Nehru Homoeopathic Medical College and ...

Earnings call Dr. Lal PathLabs reported Q3 FY26 revenue of ₹660 crore, up 10.6% YoY, driven by favorable test and geography mix. EBITDA margin (pre-exceptional) improved to 27.2% despite a ₹30 crore ...

Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...

Dr. Lal PathLabs is lining up a decisive acquisition drive to consolidate India’s hyper‑local diagnostics market, with Group CFO and International CEO Ved Goel signalling that the company is now “a ...

Dr. Lal Pathlabs Ltd has moved from a long-term downtrend towards a potential uptrend using Wyckoff structure analysis, according to SEBI-registered analyst Harshit Goel. According to Goel, the stock ...

The shares of Dr Lal PathLabs jumped more than 3 percent on October 27. This comes after the company announced that its board is set to meet on October 31 to consider a bonus issue of shares. The ...

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the instrumentation industry in ...

Dr. Lal PathLabs Q2 results FY 2024-25 date and time: Dr. Lal PathLabs has announced the date and timing of its results release for the second quarter of the fiscal year 2024-25. Along with quarterly ...